Frederick Hsu is a highly skilled research scientist currently working at Septerna as a DMPK Project Representative since October 2025. Prior experience includes a role as Scientist III at AbbVie, focusing on bioanalysis of biologics, and tenure at Pliant Therapeutics, where Frederick progressed from Associate Scientist I to Senior Research Associate II, contributing significantly to DMPK initiatives and assay development. Previous positions at Genentech and Exicure involved in vitro ADME and high-throughput synthesis processes. Frederick began the career as a DMPK Intern at Achaogen and has a strong academic foundation, holding a Master of Business Administration from the University of California, Berkeley, a Master of Science in Biotechnology from Northwestern University, and a Bachelor of Science in Biochemistry from UCLA.
This person is not in any teams
This person is not in any offices